Outcomes and characteristics of patients on protease inhibitors at a tertiary level antiretroviral clinic

Background: Protease inhibitors (PIs) have been recommended as World Health Organization second-line antiretroviral therapy (ART) for low- to middle-income countries for two decades. As dolutegravir-based regimens have become widely available, the future role of PIs is uncertain. Objectives: To des...

Full description

Bibliographic Details
Main Authors: Michele Perks, Denasha L. Reddy, Francois Venter
Format: Article
Language:English
Published: AOSIS 2023-12-01
Series:Southern African Journal of HIV Medicine
Subjects:
Online Access:https://sajhivmed.org.za/index.php/hivmed/article/view/1536